, opens new tab said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer (PFE.N) , opens new ...
Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.
Moderna lanzaría al mercado con su vacuna mRNA-1345 en 2023, luego de su aprobación regulatoria a nivel mundial. ¿Cuáles son los síntomas del virus respiratorio sincitial?
TODOS LOS EFECTOS ADVERSOS DE LA VACUNA DE MODERNA Desde los locales hasta los generales y los más o menos frecuente, todos los efectos secundarios que puede generar la vacuna desarrollada por ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
London: Moderna has won a case at the European Patent Office against Pfizer and BioNTech in a dispute over its COVID-19 vaccine, the company said on Friday. The vaccine maker has been locked in an ...
MODERNA, INC. se dedica a los medicamentos transformativos basados en el ácido ribonucleico mensajero (ARNm). Ha creado una plataforma para mejorar las propiedades farmacéuticas subyacentes de ...
NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and ...
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that the ...